Spots Global Cancer Trial Database for A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Official Title: A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Study ID: NCT06336928
Conditions
Interventions
Study Description
Brief Summary: This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.
Detailed Description: PRIMARY OBJECTIVES: I. Determine the sensitivity of LBx for the presence of breast cancer in patient cohorts II. Determine the specificity of LBx for the presence of breast cancer in all patient cohorts. OUTLINE: This is an observational study. Patients undergo blood sample collection and have their medical records reviewed on study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Keck Medicine of USC Koreatown, Los Angeles, California, United States
Los Angeles General Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States
Contact Details
Name: Anastasia Martynova, MD
Affiliation: University of Southern California
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
